Publications by authors named "Sivan Sapoznik"

Claim this Profile
C
CEACAM1 promotes melanoma cell growth through Sox-2.
Rona Ortenberg, Gilli Galore-Haskel, Ilanit Greenberg, Bella Zamlin, Sivan Sapoznik

Neoplasia· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapy.
Sivan Sapoznik, Rona Ortenberg, Gilli Galore-Haskel, Stav Kozlovski, Daphna Levy

Cancer Immunol Immunother· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel anti-melanoma immunotherapies: disarming tumor escape mechanisms.
Sivan Sapoznik, Ohad Hammer, Rona Ortenberg, Michal J Besser, Tehila Ben-Moshe

Clin Dev Immunol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel immunotherapy for malignant melanoma with a monoclonal antibody that blocks CEACAM1 homophilic interactions.
Rona Ortenberg, Yair Sapir, Lee Raz, Liat Hershkovitz, Ayelet Ben Arav, Sivan Sapoznik

Mol Cancer Ther· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum CEACAM1 Correlates with Disease Progression and Survival in Malignant Melanoma Patients.
Sapoznik Sivan, Faranesh Suzan, Ortenberg Rona, Hamburger Tamar, Barak Vivian

Clin Dev Immunol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic dysregulation of CEACAM1 in melanoma patients.
Gal Markel, Rona Ortenberg, Rachel Seidman, Sivan Sapoznik, Nira Koren-Morag

Cancer Immunol Immunother· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Ndel1 palmitoylation: a new mean to regulate cytoplasmic dynein activity.
Anat Shmueli, Michal Segal, Tamar Sapir, Ryouhei Tsutsumi, Jun Noritake, Sivan Sapoznik

EMBO J· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accurate balance of the polarity kinase MARK2/Par-1 is required for proper cortical neuronal migration.
Tamar Sapir, Sivan Sapoznik, Talia Levy, Danit Finkelshtein, Anat Shmueli

J Neurosci· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lissencephaly 1 linking to multiple diseases: mental retardation, neurodegeneration, schizophrenia, male sterility, and more.
Orly Reiner, Sivan Sapoznik, Tamar Sapir

Neuromolecular Med· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Site-specific dephosphorylation of doublecortin (DCX) by protein phosphatase 1 (PP1).
Anat Shmueli, Amos Gdalyahu, Sivan Sapoznik, Tamar Sapir, Miki Tsukada

Mol Cell Neurosci· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DCX's phosphorylation by not just another kinase (JNK).
Orly Reiner, Amos Gdalyahu, Indraneel Ghosh, Talia Levy, Sivan Sapoznik

Cell Cycle· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DCX, a new mediator of the JNK pathway.
Amos Gdalyahu, Indraneel Ghosh, Talia Levy, Tamar Sapir, Sivan Sapoznik

EMBO J· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis